866-997-4948(US-Canada Toll Free)

United States Conjugate Vaccine Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 112 Pages

Notes:
Sales, means the sales volume of Conjugate Vaccine
Revenue, means the sales value of Conjugate Vaccine

This report studies sales (consumption) of Conjugate Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Astellas Pharma Inc
CSL Limited
Emergent BioSolutions
GlaxoSmithKline
Johnson&Johnson
MedImmune
Merck
Pfizer
Sanofi Pasteur
Serum Institute
India Pvt

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Conjugate Vaccine in each application, can be divided into
Application 1
Application 2

Table of Contents

United States Conjugate Vaccine Market Report 2017
1 Conjugate Vaccine Overview
1.1 Product Overview and Scope of Conjugate Vaccine
1.2 Classification of Conjugate Vaccine
1.2.1 Type I
1.2.2 Type II
1.3 Application of Conjugate Vaccine
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Conjugate Vaccine (2012-2022)
1.4.1 United States Conjugate Vaccine Sales and Growth Rate (2012-2022)
1.4.2 United States Conjugate Vaccine Revenue and Growth Rate (2012-2022)

2 United States Conjugate Vaccine Competition by Manufacturers
2.1 United States Conjugate Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Conjugate Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Conjugate Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Conjugate Vaccine Market Competitive Situation and Trends
2.4.1 Conjugate Vaccine Market Concentration Rate
2.4.2 Conjugate Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Conjugate Vaccine Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Conjugate Vaccine Sales and Market Share by States (2012-2017)
3.2 United States Conjugate Vaccine Revenue and Market Share by States (2012-2017)
3.3 United States Conjugate Vaccine Price by States (2012-2017)

4 United States Conjugate Vaccine Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Conjugate Vaccine Sales and Market Share by Type (2012-2017)
4.2 United States Conjugate Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Conjugate Vaccine Price by Type (2012-2017)
4.4 United States Conjugate Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Conjugate Vaccine Sales (Volume) by Application (2012-2017)
5.1 United States Conjugate Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Conjugate Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Conjugate Vaccine Manufacturers Profiles/Analysis
6.1 Astellas Pharma Inc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Conjugate Vaccine Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Astellas Pharma Inc Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 CSL Limited
6.2.2 Conjugate Vaccine Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 CSL Limited Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Emergent BioSolutions
6.3.2 Conjugate Vaccine Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Emergent BioSolutions Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
6.4.2 Conjugate Vaccine Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlaxoSmithKline Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Johnson&Johnson
6.5.2 Conjugate Vaccine Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Johnson&Johnson Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 MedImmune
6.6.2 Conjugate Vaccine Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 MedImmune Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Merck
6.7.2 Conjugate Vaccine Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Merck Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Pfizer
6.8.2 Conjugate Vaccine Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Pfizer Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Sanofi Pasteur
6.9.2 Conjugate Vaccine Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Sanofi Pasteur Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Serum Institute
6.10.2 Conjugate Vaccine Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Serum Institute Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 India Pvt

7 Conjugate Vaccine Manufacturing Cost Analysis
7.1 Conjugate Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Conjugate Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Conjugate Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Conjugate Vaccine Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Conjugate Vaccine Market Forecast (2017-2022)
11.1 United States Conjugate Vaccine Sales, Revenue Forecast (2017-2022)
11.2 United States Conjugate Vaccine Sales Forecast by Type (2017-2022)
11.3 United States Conjugate Vaccine Sales Forecast by Application (2017-2022)
11.4 Conjugate Vaccine Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Conjugate Vaccine
Table Classification of Conjugate Vaccine
Figure United States Sales Market Share of Conjugate Vaccine by Type in 2015
Table Application of Conjugate Vaccine
Figure United States Sales Market Share of Conjugate Vaccine by Application in 2015
Figure United States Conjugate Vaccine Sales and Growth Rate (2012-2022)
Figure United States Conjugate Vaccine Revenue and Growth Rate (2012-2022)
Table United States Conjugate Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Conjugate Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Conjugate Vaccine Sales Share by Manufacturers
Figure 2016 Conjugate Vaccine Sales Share by Manufacturers
Table United States Conjugate Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Conjugate Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Conjugate Vaccine Revenue Share by Manufacturers
Table 2016 United States Conjugate Vaccine Revenue Share by Manufacturers
Table United States Market Conjugate Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Conjugate Vaccine Average Price of Key Manufacturers in 2015
Figure Conjugate Vaccine Market Share of Top 3 Manufacturers
Figure Conjugate Vaccine Market Share of Top 5 Manufacturers
Table United States Conjugate Vaccine Sales by States (2012-2017)
Table United States Conjugate Vaccine Sales Share by States (2012-2017)
Figure United States Conjugate Vaccine Sales Market Share by States in 2015
Table United States Conjugate Vaccine Revenue and Market Share by States (2012-2017)
Table United States Conjugate Vaccine Revenue Share by States (2012-2017)
Figure Revenue Market Share of Conjugate Vaccine by States (2012-2017)
Table United States Conjugate Vaccine Price by States (2012-2017)
Table United States Conjugate Vaccine Sales by Type (2012-2017)
Table United States Conjugate Vaccine Sales Share by Type (2012-2017)
Figure United States Conjugate Vaccine Sales Market Share by Type in 2015
Table United States Conjugate Vaccine Revenue and Market Share by Type (2012-2017)
Table United States Conjugate Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Conjugate Vaccine by Type (2012-2017)
Table United States Conjugate Vaccine Price by Type (2012-2017)
Figure United States Conjugate Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Conjugate Vaccine Sales by Application (2012-2017)
Table United States Conjugate Vaccine Sales Market Share by Application (2012-2017)
Figure United States Conjugate Vaccine Sales Market Share by Application in 2015
Table United States Conjugate Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Conjugate Vaccine Sales Growth Rate by Application (2012-2017)
Table Astellas Pharma Inc Basic Information List
Table Astellas Pharma Inc Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Pharma Inc Conjugate Vaccine Sales Market Share (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table CSL Limited Conjugate Vaccine Sales Market Share (2012-2017)
Table Emergent BioSolutions Basic Information List
Table Emergent BioSolutions Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Emergent BioSolutions Conjugate Vaccine Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Conjugate Vaccine Sales Market Share (2012-2017)
Table Johnson&Johnson Basic Information List
Table Johnson&Johnson Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson&Johnson Conjugate Vaccine Sales Market Share (2012-2017)
Table MedImmune Basic Information List
Table MedImmune Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table MedImmune Conjugate Vaccine Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Conjugate Vaccine Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Conjugate Vaccine Sales Market Share (2012-2017)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Pasteur Conjugate Vaccine Sales Market Share (2012-2017)
Table Serum Institute Basic Information List
Table Serum Institute Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Serum Institute Conjugate Vaccine Sales Market Share (2012-2017)
Table India Pvt Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Conjugate Vaccine
Figure Manufacturing Process Analysis of Conjugate Vaccine
Figure Conjugate Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Conjugate Vaccine Major Manufacturers in 2015
Table Major Buyers of Conjugate Vaccine
Table Distributors/Traders List
Figure United States Conjugate Vaccine Production and Growth Rate Forecast (2017-2022)
Figure United States Conjugate Vaccine Revenue and Growth Rate Forecast (2017-2022)
Table United States Conjugate Vaccine Production Forecast by Type (2017-2022)
Table United States Conjugate Vaccine Consumption Forecast by Application (2017-2022)
Table United States Conjugate Vaccine Sales Forecast by States (2017-2022)
Table United States Conjugate Vaccine Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *